Skip to main content

Fastest growing segment fueling the growth of Spinal Muscular Atrophy Market

 

Spinal Muscular Atrophy Market

The global Spinal Muscular Atrophy Market is estimated to be valued at US$ 1813.48 Mn or Billion in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Spinal muscular atrophy is a group of inherited diseases that causes weakness and wasting in the muscles of arms, legs, neck and face due to the loss of specialized nerve cells in the spinal cord. Spinal muscular atrophy medicines help in the treatment of spinal muscular atrophy by increasing the survival rate of motor neurons and improving muscle functions.

Market key trends:

One of the key trends in the spinal muscular atrophy market is technological advancements in gene therapies. Gene therapies are novel treatment approaches that involve modifying or manipulating genes to treat or cure disease. Major companies such as Biogen and Novartis are focusing on developing advanced gene therapies for SMA through adeno-associated virus vectors. For instance, Zolgensma by Novartis is the first and only gene therapy approved by the FDA for the treatment of SMA. It uses the AAV9 vector carrying the human SMN gene to help treat the underlying cause of SMA.

Segment Analysis:

The spinal muscular atrophy market is segmented based on type, treatment, route of administration, and distribution channel. By type, the 5q SMA segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. 5q SMA accounts for approximately 95% of all SMA cases and is the most common type among SMA patients.

Key Takeaways:

The Global Spinal Muscular Atrophy Market Growth is expected to witness high, exhibiting a CAGR of 13% over the forecast period, due to increasing awareness about SMA and the availability of newer treatment options.

Regional Analysis

North America dominated the global spinal muscular atrophy market in 2022 and is expected to continue its dominance over the forecast period. The regional growth can be attributed to the rising incidence of SMA, strong presence of key pharmaceutical companies, and rapid adoption of innovative therapies in the region.

Key Players

Key players operating in the spinal muscular atrophy market are Biogen, CYTOKINETICS, F. Hoffmann-La Roche Ltd, Genentech, Inc., PTC Therapeutics, Inc., Novartis AG, Ionis Pharmaceuticals, Chugai Pharmaceutical Co., Ltd., NMD PHARMA A/S, and Astellas Pharma Inc. With the market expected to grow at a higher rate, these players are likely to invest more in R&D for innovative treatment options.

Read More - https://www.trendingwebwire.com/spinal-muscular-atrophy-market-share-and-demand-analysis/

Comments

Popular posts from this blog

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

Global Amphibious Vehicle Market is Anticipated to Witness High Growth Owing to Growing Demand

Amphibious Transport Amphibious vehicles, commonly referred as 'amphibians', are wheeled or tracked vehicles that have the capability to travel through both land and water. They are widely used by military forces across the world for tactical mobility options. Amphibious vehicles provide unique advantages for various military operations conducted near water bodies or in flooded areas. They allow rapid deployment of troops and equipment without requiring additional logistical support. Some key uses of amphibious vehicles include border patrolling, transportation across rivers, and transportation of supplies to islands. The growing focus on military modernization programs and increasing defense budgets globally has augmented the demand for advanced amphibious vehicles. The Global Amphibious Vehicle Market is estimated to be valued at US$ 5.08 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the Globa...

Active Protection Systems Market is Anticipated to Witness High Growth

Active Protection Systems Market Active protection systems (APS) are anti-weapon defense system employed on armored fighting vehicles and tanks that protect them against incoming anti-tank missiles and rockets. An APS utilizes sensors for detecting the threat, followed by countermeasures that include projectile interceptors, direct energy weapons or smoke screens to neutralize the threat. The increasing modernization initiatives by militaries worldwide coupled with rising defense budgets is stimulating the demand for advanced protection systems for tanks and armored vehicles. The Global active protection systems market is estimated to be valued at US$ 4.30 Bn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024 to 2031. Active Protection Systems Market Growth   provides effective self-defence solutions and are becoming an integral part of the protection suites being developed for next-gen armored platforms. These systems play a crucial role in saving live...